# Harmony Biosciences Reports Q2 2026 Results and Reiterates Over $1 Billion Revenue Guidance

> news · REPORTED · 2026-08-04

Harmony Biosciences reported its second quarter 2026 financial results on August 4, 2026, before the open of US financial markets, and hosted a conference call to discuss results. The company has guided for net revenue of over $1 billion for the full year 2026.

About Harmony Biosciences Holdings, Inc.: Harmony Biosciences is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological diseases, including narcolepsy.

- Company: Harmony Biosciences Holdings, Inc.
- Sector: therapeutics
- Primary source: https://www.biospace.com/press-releases/harmony-biosciences-to-report-second-quarter-2026-financial-results-on-august-4-2026

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.